Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00796185
What this trial is testing

As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62
Post-approval studies (Phase 4)Study completedNCT00685334
What this trial is testing

Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa

Who this might be right for
Eating Disorders
New York State Psychiatric Institute 22
Large-scale testing (Phase 3)Study completedNCT00249132
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 523
Not applicableUnknownNCT04010864
What this trial is testing

Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

Who this might be right for
Clinical High-risk
Shanghai Mental Health Center 600
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Large-scale testing (Phase 3)Study completedNCT01626872
What this trial is testing

Long-Term Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 254
Large-scale testing (Phase 3)Study completedNCT01720095
What this trial is testing

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Who this might be right for
Psychosis
Nova Scotia Health Authority 22
Testing effectiveness (Phase 2)Study completedNCT00314639
What this trial is testing

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia and Schizophrenia Spectrum Psychosis
Laval University 30
Early research (Phase 1)Study completedNCT03730857
What this trial is testing

Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Calo Psychiatric Center 111
Testing effectiveness (Phase 2)Study completedNCT00770744
What this trial is testing

Efficacy of Lu 31-130 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 93
Large-scale testing (Phase 3)Study completedNCT00249119
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
Janssen, LP 1,579
Large-scale testing (Phase 3)Study completedNCT02054702
What this trial is testing

Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 97
Post-approval studies (Phase 4)Study completedNCT00330863
What this trial is testing

Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwell Health 357
Post-approval studies (Phase 4)Study completedNCT00216632
What this trial is testing

Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 99
Not applicableUnknownNCT06125275
What this trial is testing

Pattern of Acute Antipsychotic Drug- Toxicity in Children

Who this might be right for
Antipsychotic Drug- Toxicity
Assiut University 50
Not applicableStudy completedNCT01479413
What this trial is testing

Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs

Who this might be right for
Schizophrenia
Chang Gung Memorial Hospital 77
Not applicableStudy completedNCT01931059
What this trial is testing

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

Who this might be right for
Imaging of the Brain and AntipsychoticsNeuronal Network Changes
Northwell Health 11
Post-approval studies (Phase 4)Study completedNCT00237861
What this trial is testing

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Who this might be right for
Schizophrenia
Yale University
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Not applicableEnded earlyNCT02020356
What this trial is testing

Music Therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
University Hospital, Toulouse 35
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation